Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide in Myoclonus Dystonia
NCT01806805Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myoclonus dystonia (DYT11) comparing Zonisamide Sequence with Placebo Sequence (2 arms). Primary endpoint: Unified Myoclonus Rating Scale. Started Feb 2012; status: completed.
02
Drugs
zonisamide
03
Conditions
myoclonus dystonia (DYT11)
Beyond the preview
Go deeper on NCT01806805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01806805.